Position
Chief Financial Officer
Company
Pelthos Therapeutics
DurhamBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
Pelthos Therapeutics has announced the appointment of John M. Gay as Chief Financial Officer, effective April 10, 2026. Gay succeeds Francis Knuettel II and brings over 25 years of finance experience to the role
Quick answer
Pelthos Therapeutics Appoints John M. Gay as Chief Financial Officer (April 10, 2026). Pelthos Therapeutics is based in Durham, North Carolina, United States.
- Who is the new Chief Financial Officer at Pelthos Therapeutics?
- Pelthos Therapeutics named John M. Gay Chief Financial Officer, announced April 10, 2026.
- What did Pelthos Therapeutics announce on April 10, 2026?
- Pelthos Therapeutics has announced the appointment of John M. Gay as Chief Financial Officer, effective April 10, 2026.
- What does Pelthos Therapeutics do?
- Pelthos Therapeutics Inc. was formerly known as Chromocell Therapeutics Corp. Pelthos Therapeutics specializes in developing treatments for molluscum contagiosum infections.
- Where is Pelthos Therapeutics based?
- Pelthos Therapeutics is based in Durham, North Carolina, United States.
- Which similar companies made leadership changes around the same time?
- Recursion Pharmaceuticals (March 25, 2026), Aquestive Therapeutics, Inc. (March 20, 2026), MBX Biosciences, Inc. (March 10, 2026) and Cerenome, Inc. (April 9, 2026) also announced leadership changes within 45 days of Pelthos Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Recursion Pharmaceuticals Appoints Vicki Goodman, M.D., as Chief Medical Officer (March 25, 2026)
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- Plus Therapeutics Appoints Eric J. Daniels as Chief Development Officer (April 9, 2026)
- ABIVAX Appoints Michael Nesrallah as Chief Commercial Officer (April 12, 2026)
- NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer (April 13, 2026)
Who to call at Pelthos Therapeutics, and when
A new leader at Pelthos Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Pelthos Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pelthos Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pelthos Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pelthos Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pelthos Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.